SAVA Q4 2019 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$115M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$738,000

Operating Income

-$2M

Net Income

-$2M

EPS (Diluted)

$-0.08

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$589,000

Free Cash Flow

-$589,000

Stock-Based Comp.

$304,000

Balance Sheet

Total Assets

$23M

Total Liabilities

$1M

Stockholders' Equity

$22M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$738,000	-$2	-36899900.0%
Operating Income	-$2M	-$750,000	-110.1%
Net Income	-$2M	-$677,000	-123.9%